That Marketing Solution, Inc.

That Marketing Solution, Inc., a development stage company, focuses on the development, manufacturing, advertising, sale, and marketing of nutritional products. It acquired the rights to a proprietary formula for a blend of nutritional supplements called Low-T capsules that are intended to be a natural, non-FDA regulated, and over-the-counter supplement, which addresses the primary contributing factors of decreased levels of testosterone in males over the age of 30. The company was formerly known as Vista Holding Group, Corp. and changed its name to That Marketing Solution, Inc. in September 2014. That Marketing Solution, Inc. was founded in 2012 and is based in Salt Lake City, Utah.

That Marketing Solution, Inc. trades as TSTS on OTC. The company is classified in Healthcare / Medical - Pharmaceuticals and reports in USD.

The current profile places the business in Medical - Pharmaceuticals. This section is intended to summarize the operating segments, products, geographies, and main revenue lines from official filings.

Latest available fiscal data shows $495 of revenue and -$787,146 of net income.

Use this area for management strategy, capital allocation priorities, target markets, and measurable goals from the latest annual report or investor presentation.

The app now provides the structure, but exact strategic claims should come from official company documents before being treated as a finished investment thesis.

That Marketing Solution, Inc. can be compared against peers such as Acusphere, Inc., Easy Technologies Inc., IR Biosciences Holdings Inc., Ligand Pharmaceuticals Incorporated, Neptune Wellness Solutions Inc., enVVeno Medical Corporation.

A complete thesis should compare growth, margins, balance-sheet risk, valuation multiples, and market position against direct competitors.

Current signals to investigate include market capitalization of $12,754, beta of 8.85, and return on equity of +119.8%.

This section should be validated with evidence such as durable margins, brand strength, regulation, switching costs, cost advantage, distribution, or technology.

Key risks should include financial leverage, cyclicality, customer concentration, regulatory exposure, currency risk, and execution risk.

TSTS currently shows total debt of $245,109 and beta of 8.85. Missing data should be treated as a research gap, not as low risk.

Production-capacity detail is not available as structured data yet. For industrial, defense, semiconductor, or real-estate companies, this should be reviewed from annual reports and investor presentations.

No structured backlog field is available yet. If the company reports backlog, review the relevant filing section before adding it to the thesis.

Use this section for major contracts, product launches, construction projects, acquisitions, or strategic programs that can materially affect valuation.

No recent SEC-style filings are available for this symbol yet.

Customer concentration is not available as structured data here. Add it from official filings when a company discloses material customers or revenue concentration.

Supplier concentration and critical supply-chain dependencies are not available as structured data here. This should be researched from annual reports and risk disclosures.

Company website: https://www.thatmarketingsolution.com

For US-listed stocks, verify the thesis against official filings, earnings call transcripts, and company investor relations materials.